Cancer Genetics and Epigenetics, 2025, Vol.13, No.5, 236-244 http://medscipublisher.com/index.php/cge 243 Chen Y., Sun Z., Wan L., Chen H., Xi T., and Jiang Y., 2022, Tumor microenvironment characterization for assessment of recurrence and survival outcome in gastric cancer to predict chemotherapy and immunotherapy response, Frontiers in Immunology, 13: 890922. https://doi.org/10.3389/fimmu.2022.890922 Cheng X., Zhang H., Hamad A., Huang H., and Tsung A., 2022, Surgery-mediated tumor-promoting effects on the immune microenvironment, Seminars in Cancer Biology, 86(3): 408-419. https://doi.org/10.1016/j.semcancer.2022.01.006 De Visser K., and Joyce J., 2023, The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth, Cancer Cell, 41(3): 374-403. https://doi.org/10.1016/j.ccell.2023.02.016 Fuster-Anglada C., Mauro E., Ferrer-Fábrega J., Caballol B., Sanduzzi-Zamparelli M., Bruix J., Fuster J., Reig M., Díaz A., and Forner A., 2024, Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection, Journal of Hepatology, 81(6): 995-1004. https://doi.org/10.1016/j.jhep.2024.06.018 Giuliani T., Montalvá E., Maupoey J., Boscà A., Hernando A., Calatayud D., Navarro V., Rubín Á., Vinaixa C., and López-Andújar R., 2024, Recurrence of hepatocellular carcinoma after liver transplantation: clinical patterns and hierarchy of salvage treatments, Digestive Surgery, 41(4): 181-193. https://doi.org/10.1159/000539460 Goenka A., Khan F., Verma B., Sinha P., Dmello C., Jogalekar M., Gangadaran P., and Ahn B., 2023, Tumor microenvironment signaling and therapeutics in cancer progression, Cancer Communications, 43: 525-561. https://doi.org/10.1002/cac2.12416 Hsiao C., Ho C., Ho M., Cheng H., Wu Y., Lee P., and Hu R., 2024, Risk factors patterns and outcome predictors of late recurrence in patients with hepatocellular carcinoma after curative resection: a large cohort study with long-term follow-up results, Surgery, 176(1): 2-10. https://doi.org/10.1016/j.surg.2024.02.006 Hwang J., Kim S., Bang H., Kim H., Shim H., Bae W., Chung I., Sun E., Lee T., Ock C., Nam J., and Cho S., 2024, Tumor immune microenvironment biomarkers for recurrence prediction in locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy, Cancers, 16(19): 3353. https://doi.org/10.3390/cancers16193353 Jang E., Choi H., You Y., Seo D., Kwon M., Yang K., Lee J., Jang J., Yoon S., Han J., and Sung P., 2025, Differential infiltration of T-Cell populations in tumor and liver tissues predicts recurrence-free survival in surgically resected hepatocellular carcinoma, Cancers, 17(9): 1548. https://doi.org/10.3390/cancers17091548 Jia Q., Wang A., Yuan Y., Zhu B., and Long H., 2022, Heterogeneity of the tumor immune microenvironment and its clinical relevance, Experimental Hematology and Oncology, 11(1): 24. https://doi.org/10.1186/s40164-022-00277-y Kim J., Kang W., Sinn D., Gwak G., Paik Y., Choi M., Lee J., Koh K., and Paik S., 2020, Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients, Clinical and Molecular Hepatology, 26: 516-528. https://doi.org/10.3350/cmh.2020.0016 Kim S., and Cho S., 2022, The evasion mechanisms of cancer immunity and drug intervention in the tumor microenvironment, Frontiers in Pharmacology, 13: 868695. https://doi.org/10.3389/fphar.2022.868695 Lee I., Huang J., Chen T., Yen C., Chiu N., Hwang H., Huang J., Liu C., Chau G., Lee R., Hung Y., Chao Y., Ho S., and Huang Y., 2021, Evolutionary learning-derived clinical-radiomic models for predicting early recurrence of hepatocellular carcinoma after resection, Liver Cancer, 10: 572-582. https://doi.org/10.1159/000518728 Liu S., Jia M., and Dai R., 2023, Deciphering the tumour immune microenvironment of hepatocellular carcinoma, Scandinavian Journal of Immunology, 98(5): e13327. https://doi.org/10.1111/sji.13327 Maus R., Leontovich A., Moore R., Fogarty Z., Guo R., Davidson T., Tekin B., Atherton C., Schimke J., Dicke B., Chen B., and Markovic S., 2022, Quantitative spatial evaluation of tumor-immune interactions in the immunotherapy setting of metastatic melanoma lymph nodes, Frontiers in Immunology, 13: 1024039. https://doi.org/10.3389/fimmu.2022.1024039 Mundhara N., and Sadhukhan P., 2024, Cracking the codes behind cancer cells’ immune evasion, International Journal of Molecular Sciences, 25(16): 8899. https://doi.org/10.3390/ijms25168899 She S., Shi J., Zhu J., Yang F., Yu J., and Dai K., 2024, Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy, Cancer Medicine, 13(4): e7018. https://doi.org/10.1002/cam4.7018 Shrestha P., Ghoreyshi Z., and George J., 2024, How modulation of the tumor microenvironment drives cancer immune escape dynamics, Scientific Reports, 15(1): 7308. https://doi.org/10.1101/2024.08.16.608314 Straś W., Wasiak D., Łągiewska B., Tronina O., Hreńczuk M., Gotlib J., Lisik W., and Małkowski P., 2022, Recurrence of hepatocellular carcinoma after liver transplantation: risk factors and predictive models, Annals of Transplantation, 27: e934924-1. https://doi.org/10.12659/AOT.934924 Sun W.M., 2024, Global epidemiology of hepatitis B and implications for vaccine strategies, Journal of Vaccine Research, 14(3): 107-119. https://doi.org/10.5376/jvr.2024.14.0012
RkJQdWJsaXNoZXIy MjQ4ODYzNA==